BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27160240)

  • 41. Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology.
    Sechi A; Nucifora G; Piccoli G; Dardis A; Bembi B
    BMC Cardiovasc Disord; 2014 Jul; 14():86. PubMed ID: 25026990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genotype-phenotype analysis of Fabry disease caused by GLA gene variation in a pedigree].
    Ge ZH; Lu ZH; Pan XD; Lai TT; Yang MJ; Yang HQ; Zhang HB; Li GY; Dai ZQ; Mao JH
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):345-350. PubMed ID: 38527505
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
    Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
    Sachdev B; Takenaka T; Teraguchi H; Tei C; Lee P; McKenna WJ; Elliott PM
    Circulation; 2002 Mar; 105(12):1407-11. PubMed ID: 11914245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac Anderson-Fabry disease: lessons from a 25-year-follow up.
    Brito D; Miltenberger-Miltenyi G; Moldovan O; Navarro C; Madeira HC
    Rev Port Cardiol; 2014 Apr; 33(4):247.e1-7. PubMed ID: 24830310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.
    Havndrup O; Christiansen M; Stoevring B; Jensen M; Hoffman-Bang J; Andersen PS; Hasholt L; Nørremølle A; Feldt-Rasmussen U; Køber L; Bundgaard H
    Eur J Heart Fail; 2010 Jun; 12(6):535-40. PubMed ID: 20498269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A).
    Lin HY; Huang CH; Yu HC; Chong KW; Hsu JH; Lee PC; Cheng KH; Chiang CC; Ho HJ; Lin SP; Chen SJ; Lin PK; Niu DM
    J Inherit Metab Dis; 2010 Oct; 33(5):619-24. PubMed ID: 20821055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel A97P amino acid substitution in alpha-galactosidase A leads to a classical Fabry disease with cardiac manifestations.
    Kimura K; Sato-Matsumura KC; Nakamura H; Onodera Y; Morita K; Enami N; Shougase T; Ohsaki T; Kato M; Takahashi T; Yamaguchi Y; Shimizu H
    Br J Dermatol; 2002 Sep; 147(3):545-8. PubMed ID: 12207598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Two novel mutations of GLA gene in Chinese patients with Fabry disease].
    An GP; An FS; Zhang Y; Zou YX; Zhang C; Jiang H; Feng JB; Wang R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Mar; 35(3):212-5. PubMed ID: 17582282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.
    San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR
    Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic screening and double mutation in Japanese patients with hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Baba Y; Hirota T; Hayato K; Yamasaki N; Matsumura Y; Otsuka H; Arimura T; Kimura A; Doi YL
    Circ J; 2011; 75(11):2654-9. PubMed ID: 21799269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.
    Lopes LR; Syrris P; Guttmann OP; O'Mahony C; Tang HC; Dalageorgou C; Jenkins S; Hubank M; Monserrat L; McKenna WJ; Plagnol V; Elliott PM
    Heart; 2015 Feb; 101(4):294-301. PubMed ID: 25351510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.
    Schiffmann R; Forni S; Swift C; Brignol N; Wu X; Lockhart DJ; Blankenship D; Wang X; Grayburn PA; Taylor MR; Lowes BD; Fuller M; Benjamin ER; Sweetman L
    J Am Heart Assoc; 2014 Feb; 3(1):e000394. PubMed ID: 24496231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late-onset Fabry disease: the cardiac sequela.
    Tremblay J; Kim S; Philbin E; Beers K; Lightle A; Belov D
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a novel nonsense mutation in α-galactosidase A that causes Fabry disease in a Chinese family.
    Peng Y; Pan M; Wang Y; Shen Z; Xu J; Xiong F; Xiao H; Miao Y
    Ren Fail; 2024 Dec; 46(2):2362391. PubMed ID: 38847497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA methylation impact on Fabry disease.
    Di Risi T; Vinciguerra R; Cuomo M; Della Monica R; Riccio E; Cocozza S; Imbriaco M; Duro G; Pisani A; Chiariotti L
    Clin Epigenetics; 2021 Feb; 13(1):24. PubMed ID: 33531072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the p.E66Q variant of GLA in the progression of chronic kidney disease.
    Watanabe H; Goto S; Miyashita A; Maruyama H; Wakasugi M; Yokoseki A; Kuwano R; Narita I
    Clin Exp Nephrol; 2015 Apr; 19(2):225-30. PubMed ID: 24718812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.
    Lin HY; Chong KW; Hsu JH; Yu HC; Shih CC; Huang CH; Lin SJ; Chen CH; Chiang CC; Ho HJ; Lee PC; Kao CH; Cheng KH; Hsueh C; Niu DM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):450-6. PubMed ID: 20031620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deciphering the diagnostic dilemma: A comprehensive review of the Taiwanese cardiac variant in Fabry disease.
    Hwu WL
    J Formos Med Assoc; 2024 Jul; 123(7):738-743. PubMed ID: 37833114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.